Galanin-R1 receptor mRNA expression in the hypothalamus of the Brattelboro rat

NeuroReport

Volumn 10, Issue 13, 1999, Pages 2823-2827

  Landry, Marc ^b   Åman, Katarina ^c   Burlet, Arlette ^a   Hökfelt, Tomas ^c  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c NONE

Author keywords

Autoreceptors; Hyperosmotic stimulus; In situ hybridization; Neuropeptide; Paraventricular nucleus; Supraoptic nucleus

Indexed keywords

GALANIN RECEPTOR; MESSENGER RNA; NEUROPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HYPOTHALAMUS; IN SITU HYBRIDIZATION; LIGAND BINDING; MESSENGER RNA SYNTHESIS; NONHUMAN; OSMOTIC STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; STIMULUS RESPONSE; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS;

EID: 17544402363     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199909090-00023     Document Type: Article

References (31)

1. Tatemoto K, Rökaeus Å, Jörnvall H et al. FEBS Lett 164, 124-128 (1983).
2. Hökfelt T, Bartfai T and Crawley J. eds. Basic Research Discoveries and Thereapeutic Implications. London: MacMillan, 1998.
3. Skofitsch G, Sills MA and Jacobowitz M. Peptides 7, 1029-1042 (1986).
4. Palazzi E, Fisone G, Hökfelt T et al. Eur J Pharmacol 148, 479-480 (1988).
5. Lagny-Pourmir I and Epelbaum J. Neuroscience 49, 829-848 (1992).
6. Habert-Ortoli E, Amiranoff B, Loquet I et al. Proc Natl Acad Sci USA 91, 9780-9783 (1994).
7. Burgevin MC, Loquet I, Quarterenot D and Habert-Ortoli E. J Mol Neurosci 6, 33-41 (1995).
8. Parker EM, Izzarelli DG, Nowak HP. et al. Mol Brain Res 34, 179-189 (1995).
9. Mitchell VE, Habert-Ortoli E, Epelbaum J et al. Neuroendocrinology 66, 160-172 (1997).
10. Landry M, Àman K and Hökfelt T. J Comp Neurol 399, 321-340 (1998).
11. H?kfelt T, Zhang X and Wiesenfeld-Hallin Z, Trends Neurosci 17, 22-30 (1994).
12. Cortés R, Villar MJ, Verhofstad A and Hökfelt T, Proc Natl Acad Sci USA 87, 7742-7746 (1990).
13. Agoston DV, Komoly S and Palkovits M. Exp Neurol 126, 247-255 (1994).
14. Xu ZQ, Shi TJ, Landry M and Hökfelt T. NauroReport 8, 237-242 (1996).
15. Planas B, Kolb PE, Raskind MA and Miller MA. Neuroendocrinology 51, 646-654 (1995).
16. Rökaeus Å, Young IWS and Mezey E. Neurosci Lett 90, 45-50 (1988).
17. Skolitsch G, Jacobowitz DM, Amann R and Lembeck F. Neuroendocrinology 49, 419-427 (1989).
18. Meister B, Cortés R, Villar MJ et al. Cell Tissue Res 260, 279-97 (1990).
19. Young WS, Horváth S and Palkovits M. Neuroscience 39, 115-125 (1990).
20. Melander T, Hökfelt T, Rökaous Å et al. J Neurosci 6, 3640-3654 (1986).
21. Kondo K, Murase T, Otake K et al. Neurosci Lett 128, 245-248 (1991).
22. Landry M, Roche D and Calas A. Neuroendocrinology 61, 393-404 (1995).
23. Schmale H and Richter D. Nature 309, 258-261 (1984).
24. Van Leuween FW, Prog Brain Res 92, 149-155 (1992).
25. Morris JF, DV Pow, HW Sokol and Ward A. Dendritic release of peptides from magnocellular neurons in normal rats, Brattleboro rats and mice with hereditary nephrogenic diabetes insipidus, In: Gross P Richter D and Robertson GL, eds. Vasopressin. Paris: John Libbey Eurotext, 1993: 171-182.
26. Sawchenko PE and Pfeiffer SW. Brain Res 474, 231-245 (1988).
27. Landry M and Hökfelt T. Neuroscience 84, 897-912 (1998).
28. Papas S and Bourque CW. J Neurosci 17, 6048-6056 (1997).
29. Gaymann W and Falke N. Neurosci Lett 112, 114-119 (1990).
30. Howard AD, Tan C, Shiao LL et al. FEBS Lett 405, 285-290 (1997).
31. O'Donnell D, Ahmad S Wahlestedt C and Walker P. J Comp Neurol 409, 469-481 (1999).